Posts Tagged ‘cardiovascular disease’

Is Insomnia Linked to High Blood Pressure?

insomnia clinical trialWith more than 1,000 clinical trials underway at Emory, today’s research is giving patients and families a better tomorrow. Read about one of our active nursing clinical trials below:

Hypertension, or high blood pressure, is a common but serious condition. According to the Centers for Disease Control and Prevention, about 1 in every 3 adults in the United States (about 70 million people) has high blood pressure.

Having high blood pressure means the pressure of blood in the blood vessels is higher than it should be, which can be a risk factor for heart disease and stroke, two of the leading causes of death for Americans.

While hypertension can be controlled through prescribed medications, lifestyle changes are equally as important. A healthy diet and exercise are known ways to lower blood pressure, but a clinical trial currently underway at the Nell Hodgson Woodruff School of Nursing at Emory University is investigating whether adequate sleep also helps reduce high blood pressure.

Insomnia – or trouble getting to sleep, staying asleep or early morning awakenings – is a very common sleep disorder associated with decreased quality of life, reduced work productivity and increased health care costs. In recent years, insomnia has also been associated with hypertension and cardiovascular disease.

In this particular study, funded by the American Heart Association, participants participate in an online sleep improvement program once a week for six weeks. The goal of the trial is to determine if the program is effective in lowering blood pressure and improving sleep, mood and cognition in people with insomnia and high blood pressure.

Do you have high blood pressure? Do you have trouble sleeping? Eligible participants will receive compensation for their time and effort. For more information, click to view the informational flyer for this trial>>

Related Resources

Find an Emory trial
Clinical Trials – FAQs
Understanding Clinical Trials – Part 1: What are Clinical Trials?
Emory School of Nursing

Center for Translational Cardiovascular Nanomedicine – Emory & Georgia Tech Researchers Receive new $14M contract from NIH

Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.

The Center for Translational Cardiovascular Nanomedicine will be directed by Dr. Gang Bao, Professor of Biomedical Engineering and Emory University and Georgia Tech.

Contributors from Emory University include: Dr. W. Robert Taylor, Director of Cardiology; Department of Medicine chair Dr. R. Wayne Alexander; Division of Cardiology faculty including Dr. David Harrison, Dr. Young-sup Yoon, and Dr. Charles Searles; Department of Biomedical Engineering Faculty including Dr. Michael Davis, Dr. Hanjoong Jo, Dr. Shuming Nie, and Dr. Xiaoping Hu; and Department of Radiology professor Mark Goodman. Contributors from Georgia Tech include: Wallace H. Coulter Department of Biomedical Engineering faculty including Dr. Don Giddens, Dr. Niren Murthy, and Dr. May Dongmei Wang.

Goals for this five-year study include the following:

  • Using nanoparticle probes to image and characterize atherosclerotic plaques
  • Diagnosing cardiovascular disease from a blood sample
  • Designing new methods for delivering anti-atherosclerosis drugs and genes into the body
  • Developing stem cell based therapies to repair damaged heart tissue

We’ll continue to keep you posted on the developments of the Center and on diagnoses and treatments of atherosclerosis that come from the study.